By expenditures
| Name | Title | Type |
|---|---|---|
| Christine Garczynski | Director Of Finance | Auditee |
| Cheri Amoss | Principal | Auditee |
| Gregory Bussink | PRINCIPAL | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 396377 | 2025 | 2026-03-30 | CLIFTONLARSONALLEN LLP | $144.56M |
| 349937 | 2024 | 2025-03-28 | Cliftonlarsonallen LLP | $207.96M |
| 301897 | 2023 | 2024-04-01 | Cliftonlarsonallen LLP | $257.75M |
| 55559 | 2022 | 2023-03-29 | Cliftonlarsonallen LLP | $251.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 396377 | 2025 | 2026-03-30 | 1204630 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204629 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204628 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204627 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204626 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204625 | 2025-006 | Material Weakness | Yes | L |
| 396377 | 2025 | 2026-03-30 | 1204624 | 2025-005 | Material Weakness | Yes | AB |
| 396377 | 2025 | 2026-03-30 | 1204623 | 2025-005 | Material Weakness | Yes | AB |
| 349937 | 2024 | 2025-03-28 | 1115831 | 2024-007 | Significant Deficiency | - | N |
| 349937 | 2024 | 2025-03-28 | 1115830 | 2024-006 | Significant Deficiency | - | G |
| 349937 | 2024 | 2025-03-28 | 1115829 | 2024-006 | Significant Deficiency | - | G |
| 349937 | 2024 | 2025-03-28 | 1115828 | 2024-005 | Significant Deficiency | - | N |
| 349937 | 2024 | 2025-03-28 | 1115827 | 2024-004 | Significant Deficiency | - | M |
| 349937 | 2024 | 2025-03-28 | 539389 | 2024-007 | Significant Deficiency | - | N |
| 349937 | 2024 | 2025-03-28 | 539388 | 2024-006 | Significant Deficiency | - | G |
| 349937 | 2024 | 2025-03-28 | 539387 | 2024-006 | Significant Deficiency | - | G |
| 349937 | 2024 | 2025-03-28 | 539386 | 2024-005 | Significant Deficiency | - | N |
| 349937 | 2024 | 2025-03-28 | 539385 | 2024-004 | Significant Deficiency | - | M |